Zhejiang Xinguang Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2018
April 18, 2019 at 02:36 pm EDT
Share
Zhejiang Xinguang Pharmaceutical Co., Ltd. announced earnings results for the full year ended December 31, 2018. For the full year, the company announced sales was CNY 276.257 million compared to CNY 310.865 million a year ago. Operating income was CNY 101.042 million compared to CNY 122.511 million a year ago. Net income was CNY 87.995 million compared to CNY 106.159 million a year ago. Basic earnings per share from continuing operations was CNY 0.55 compared to CNY 0.66 a year ago.
Zhejiang Xinguang Pharmaceutical Co Ltd is a China-based company mainly engaged in the research, development, production and sales of Chinese patent medicines, chemical medicines and health foods. The Company's main products are Huangqishengmaiyin, Shenjindan Capsules, American Ginseng Oral Liquid and other products. The treatment scope is mainly cardiovascular and cerebrovascular diseases, trauma diseases, and covers respiratory system, digestive system, urinary system, pediatric diseases and improving immunity. The Company operates its businesses mainly in domestic markets, with Zhejiang Province as its major market.